Answers are grounded in this paper and cite their sources.
In vivo study demonstrates reduced tumor growth from punicalagin in an endometrial cancer xenograft model, suggesting strong efficacy with low toxicity.
studies using a xenograft mouse model showed that treatment with PCG significantly reduced tumor volume and weight, whereas body weight was not significantly affected, thus highlighting strong anticancer efficacy coupled with very low toxicity. Overall, the present study highlights PCG as a promising natural compound with multitarget anticancer activity against EC and warrants further preclinical and clinical research as a potential treatment option.
No takes yet. Share an insight, caveat, or question.
Bhutta et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: